. The median peak labelling positions were cell 26 (GB) and cell 61 (GA) from the crypt orifice. The mean crypt labelling indices were 2-8% (GB) and 4-8% (GA). The mean Ts of GA cells was 7 7 hours and of GB cells was 10 8 hours. (Gut 1993; 34: 893-896) surgical gastric mucosal biopsy specimens from various anatomical sites. Multiparametric flow cytometric analysis allows dynamic data on cell kinetics to be obtained from a single injection and biopsy specimen."'6 In particular, for the purposes ofthis study, it can measure the S phase duration (in hours) of crypt cells in gastric mucosa. From these data, the crypt growth fraction, the cell cycle time, and the crypt turnover time can also be estimated.
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The relative complexity of gastric crypt anatomy compared with colorectal mucosa has discouraged its use as an experimental model in proliferation research. Gastric mucosa is nevertheless a structured, spatially organised tissue of considerable clinical and biological importance. The study of the proliferation of human gastric mucosa may provide clues to the development of invasive adenocarcinoma, ulcers, mucosal erosions, and to the actions ofputative mutagenic drugs in the stomach.
Methods

DRUG ADMINISTRATION
The study was made on full thickness tissues excised from surgical resection specimens in conjunction with an in vivo labelling study of primary gastric or oesophageal carcinomas. Each patient gave consent to have a single intravenous dose of 250 mg 5-bromo 2-deoxyuridine (BrdUrd) (Takeda, Japan) given over 30 seconds in 10 ml saline, between 3-0 and 15- BrdUrd labelling was confined to the superficial zone of human gastric crypts (Fig 1) . Up to 50 histologically normal crypts were analysed from each specimen where the entire proliferating compartment was contained within the longitudinal fragment of the crypt selected for counting. Position one was chosen as the first cell in the vertical column at the crypt orifice (Fig 2) as a reference point for the computer program. This was in contrast with other scoring studies, where the reference point was fixed at the crypt base. Fifty half crypt sections were scored for each sample. Scoring was performed for each cell along the crypt column to a point immediately beyond the proliferative zone where crypt continuity was lost. Slides were scored under a x 40 oil objective. The abscissa scale has been reversed to aid comparisons with colorectal data.9 10 (10 10 underwent total gastrectomies, and seven had partial gastrectomies. There was one modified Whipple's procedure.
CELL COUNTING
There were 780 pooled hemicrypts of gastric body mucosa (n= 16) and 500 pooled hemicrypts of antral mucosa (n= 10). The Table and Figure  3 shows the results.
STATIC INDICES
The total mean crypt labelling index was 2-8% in gastric body mucosa compared with 4-8% in Figure 3 shows the distribution of the crypts described by the median value, 5th and 95th percentiles. Significant differences (p=0 001) were found between these two gastric regions with regard to s of crypt length, size of the proliferating compartinn-ment, and the position of peak labelling. The test overall growth fraction (<20%) was similar in A both antral and body mucosa.
DYNAMIC AND FLOW CYTOMETRY DATA
The flow cytometrically derived S phase duration was similar in gastric body and antral cells. (All normal mucosal specimens had diploid ned DNA profiles.) The median Ts of gastric body 1ical mucosa was estimated to be hours (range 19), 3-8-19-7 hours) and of antral mucosa to be 7-3 eso-hours (4-1-12-8 hours). The cell cycle time was rere estimated to be similar in both regions of iges mucosa, but the crypt turnover time seemed to iree be significantly longer (28* 1 days) in gastric body tro-than in antral (11 5 (Fig 1) . In vivo BrdUrd based studies, however, have serious practical limitations. Although BrdUrd appears to be safe for in vivo pulse labelling studies in low dose by the intravenous route, its use in vivo is confined to the study of malignancy. '8 In vitro incubations of fresh gastric mucosal biopsy specimens with BrdUrd or tritiated thymidine overcome the constraints of in vivo labelling at the cost of the loss of the dynamic function of pulse labelling. Studies of crypts labelled in vivo with BrdUrd may provide a reference against which other putative intrinsic proliferation markers such as Ki-67 and proliferating cell nuclear antigen may be assessed. By these means it is hoped that further understanding of gastric mucosal proliferation and its controls in normal conditions and in disease may be achieved. 
